Inferences of individual differences in response to tripterysium glycosides across patients with Rheumatoid arthritis using a novel ceRNA regulatory axis

BACKGROUND: To identify biomarkers for guiding therapy and predicting clinical response of Tripterysium Glycosides Tablets (TGT) treatment is an urgent task due to individual differences in TGT response across rheumatoid arthritis (RA) patients. Competing endogenous RNA (ceRNA) regulatory system may...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanqiong, Wang, Xiaoyue, Li, Weijie, Wang, Hailong, Yin, Xiaoli, Jiang, Funeng, Su, Xiaohui, Chen, Wenjia, Li, Taixian, Mao, Xia, Guo, Minqun, Jiang, Quan, Lin, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545341/
https://www.ncbi.nlm.nih.gov/pubmed/33135351
http://dx.doi.org/10.1002/ctm2.185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545341/
https://www.ncbi.nlm.nih.gov/pubmed/33135351
http://dx.doi.org/10.1002/ctm2.185

Ejemplares similares